Ardelyx Inc (ARDX)
8.465
-0.82
(-8.78%)
USD |
NASDAQ |
May 08, 16:00
8.45
-0.02
(-0.18%)
After-Hours: 19:39
Ardelyx Cash from Operations (Quarterly): -35.72M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -35.72M |
| December 31, 2023 | -8.718M |
| September 30, 2023 | -21.47M |
| June 30, 2023 | -14.74M |
| March 31, 2023 | -44.80M |
| December 31, 2022 | 14.28M |
| September 30, 2022 | -25.43M |
| June 30, 2022 | -31.28M |
| March 31, 2022 | -27.62M |
| December 31, 2021 | -39.47M |
| September 30, 2021 | -34.59M |
| June 30, 2021 | -34.28M |
| March 31, 2021 | -44.22M |
| December 31, 2020 | -17.59M |
| September 30, 2020 | -19.88M |
| June 30, 2020 | -19.02M |
| March 31, 2020 | -24.95M |
| December 31, 2019 | -11.14M |
| September 30, 2019 | -20.61M |
| June 30, 2019 | -27.82M |
| March 31, 2019 | -16.91M |
| December 31, 2018 | -18.44M |
| September 30, 2018 | -27.02M |
| Date | Value |
|---|---|
| June 30, 2018 | -18.02M |
| March 31, 2018 | -6.804M |
| December 31, 2017 | 4.698M |
| September 30, 2017 | -19.24M |
| June 30, 2017 | -23.89M |
| March 31, 2017 | -26.76M |
| December 31, 2016 | -26.75M |
| September 30, 2016 | -24.64M |
| June 30, 2016 | -24.90M |
| March 31, 2016 | -16.25M |
| December 31, 2015 | -21.60M |
| September 30, 2015 | -11.80M |
| June 30, 2015 | -30.22M |
| March 31, 2015 | -8.209M |
| December 31, 2014 | -3.792M |
| September 30, 2014 | -5.685M |
| June 30, 2014 | 23.99M |
| March 31, 2014 | -1.12M |
| December 31, 2013 | 10.91M |
| September 30, 2013 | -0.199M |
| June 30, 2013 | -4.772M |
| March 31, 2013 | -4.125M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-44.80M
Minimum
Mar 2023
14.28M
Maximum
Dec 2022
-24.45M
Average
-25.19M
Median
Cash from Operations (Quarterly) Benchmarks
| Nektar Therapeutics | -47.05M |
| Rigel Pharmaceuticals Inc | -6.24M |
| Omeros Corp | -34.82M |
| Vistagen Therapeutics Inc | -4.535M |
| Karyopharm Therapeutics Inc | -18.58M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.572M |
| Cash from Financing (Quarterly) | 52.97M |
| Free Cash Flow | -81.12M |
| Free Cash Flow Per Share (Quarterly) | -0.1539 |
| Free Cash Flow to Equity (Quarterly) | -85.88M |
| Free Cash Flow to Firm (Quarterly) | -31.80M |
| Free Cash Flow Yield | -4.22% |